Findings

What do systematic reviews say?

14 questions · 14 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 9 · 64.3%GRADE not reported 0 · 0%Very low 3 · 21.4%Low 2 · 14.3%Moderate 0 · 0%High 0 · 0%

Cannabis cigarettes vs placebo

CRP (mg/dL) at end of study · people with active UC

1 finding from 1 review

Cannabis for the treatment of ulcerative colitis 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 28 participants
Low

Cannabis cigarettes vs placebo

Health‐related quality of life (timeframe not reported) ‐ IBDQ ‐ Symptoms‐guided diet · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of ulcerative colitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis cigarettes vs placebo

Adverse events · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of ulcerative colitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis cigarettes vs placebo

Serious adverse events · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of ulcerative colitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis cigarettes vs placebo

Withdrawals due to adverse events · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of ulcerative colitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis cigarettes vs placebo

Clinical remission · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of ulcerative colitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis cigarettes vs placebo

Clinical response · people with active UC

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of ulcerative colitis 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis cigarettes (115 mg THC) vs placebo cigarettes

Clinical remission · Patients with active Crohn's disease

It is very uncertain whether cannabis cigarettes (115 mg THC) changes proportion of patients achieving clinical remission compared with placebo cigarettes (very low certainty).

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
RR 4.55 [0.63, 32.56]
1 study · 21 participants
Very low

Cannabis cigarettes (115 mg THC) vs placebo cigarettes

Proportion of patients achieving clinical response · Patients with active Crohn's disease

It is very uncertain whether cannabis cigarettes (115 mg THC) changes proportion of patients achieving clinical response compared with placebo cigarettes (very low certainty).

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
RR 2.27 [1.04, 4.97]
1 study · 21 participants
Very low

Cannabis cigarettes (115 mg THC) vs placebo cigarettes

CRP (mg/dL) at end of study · Patients with active Crohn's disease

Cannabis cigarettes (115 mg THC) showed no clear difference in CRP (mg/dL) at end of study compared with placebo cigarettes (low certainty).

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
RR 1.36 [0.28, 6.56]
1 study · 21 participants
Low

Cannabis cigarettes (115 mg THC) vs placebo cigarettes

Quality of life Short‐Form 36 health survey (SF‐36) · Patients with active Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis cigarettes (115 mg THC) vs placebo cigarettes

Adverse events · Patients with active Crohn's disease

It is very uncertain whether cannabis cigarettes (115 mg THC) changes adverse events compared with placebo cigarettes (very low certainty).

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
RR 4.09 [1.15, 14.57]
1 study · 21 participants
Very low

Cannabis cigarettes (115 mg THC) vs placebo cigarettes

Serious adverse events · Patients with active Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis cigarettes (115 mg THC) vs placebo cigarettes

Withdrawals due to adverse events · Patients with active Crohn's disease

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis for the treatment of Crohn's disease 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found